FDA Adverse Event Malfunction Summary report: N

ELECSYS CMV IGM

MDR report key: 20129424 · Received September 3, 2024

Report

Report Number
1823260-2024-02542
Event Type
Malfunction
Date Received
September 3, 2024
Date of Event
August 9, 2024
Report Date
October 18, 2024
Manufacturer
ROCHE DIAGNOSTICS
Product Code
LFZ
UDI-DI
04015630940189
PMA / PMN Number
K163569
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
LU
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

INVESTIGATION OF THE PROVIDED PATIENT SAMPLE MATERIAL FOUND THE CUSTOMER'S NON-REACTIVE ELECSYS CMV IGM RESULTS WERE REPRODUCIBLE. THE NON-REACTIVE ELECSYS CMV IGM RESULT WAS CONFIRMED BY THE RECOMLINE CMV IGM BLOT (MIKROGEN). THE INVESTIGATION DETERMINED THE SAMPLE WAS CONSISTENT WITH AN ACUTE PRIMARY CMV INFECTION (2-3 MONTHS AGO) DUE TO THE DETECTION OF LOW IGG TITERS WITH A LOW CMV IGG AVIDITY AND A DECLINING CMV IGM REACTIVITY BELOW THE BORDERLINE RANGE. THE INVESTIGATION DID NOT IDENTIFY A PRODUCT PROBLEM.

Additional Manufacturer Narrative · 0

THE COBAS E 801 MODULE SERIAL NUMBER WAS (B)(6). SAMPLE MATERIAL FROM THE PATENT WAS REQUESTED FOR INVESTIGATION.

Description of Event or Problem · 0

THERE WAS AN ALLEGATION OF QUESTIONABLE ELECSYS CMV IGM RESULTS FROM THE COBAS E 801 MODULE. THE ROCHE IGM RESULT WAS 0.3 (NEGATIVE) REPEATEDLY. THE BIOMERIEUX IGM RESULT WAS 1.72 (POSITIVE).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
735203 ELECSYS CMV IGM ENZYME LINKED IMMUNOABSORBENT ASSAY, CYTOMEGALOVIRUS LFZ ROCHE DIAGNOSTICS 764032 04015630940189

Patients

Seq Age Sex Outcome Treatment
1 55 YR Female